retatrutide review is a new weight-loss injection, which is currently in its final stages of safety and efficacy trials. UK approval is likely in 2027, pending full MHRA review. Developed by Eli Lilly Retatrutide Promises Big Weight Loss,

Cellular and Medical Aspects , Greenwald G., Cohen R

Evidence From Preclinical & Clinical Studies A) Skin permeation & bioavailability In-vitro penetration: A Franz-cell model showed human skin penetration of GHK-Cu in vitro, supporting the feasibility of topical delivery (PMC)

The GLP-1 receptor arm drives glucose-dependent insulin secretion alongside suppression of pancreatic alpha-cell glucagon output, slows gastric emptying, and engages central nervous system appetite-modulating circuits in the hypothalamus and brainstem (PMID 39515565)

Supports Mental Clarity: Increases in endorphins can enhance mental clarity and cognitive function